Mercury Laboratories informs about change in management

14 Jun 2024 Evaluate
Pursuant to Regulation 30 read with Para A (7) of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), Mercury Laboratories has informed that Jagdish Patil has been appointed as Head of the Department (Dept.-Injectable Production) of the Company with effect from June 14, 2024. The details of changes as required under Regulation 30 of SEBI (LODR) Regulations, 2015 read with Section V-A of Chapter V of Master Circular issued vide circular no. SEBI/HO/CFD/PoD2/CIR/P/2023/120 dated July 11, 2023 and SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023 is enclosed as Annexure-A.

The above information is a part of company’s filings submitted to BSE.

Mercury Laboratories Share Price

878.80 6.00 (0.69%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×